相关实验视频

Updated: Jan 10, 2026

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals

Published on: March 23, 2016

在兽医和人类医学中Ivermectin的治疗和配方进展

Nicezelle Gernandt¹, Chanri Wentzel¹, Daniélle van Staden¹

¹Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), North-West University, Potchefstroom 2531, South Africa.

|November 27, 2025

概括

伊弗梅克丁 (IVM) 是一种多用途的抗寄生虫药物,有效应对动物和人类的各种感染. 通过量身定制的剂量形式优化其输送对于增强其治疗潜力和解决耐药性至关重要.

科学领域:

兽医医学兽医医学兽医医学
寄生虫学的寄生虫学
药理学药理学是指药理学的学科.

背景情况:

伊弗梅克丁 (IVM) 是一种广泛的抗寄生虫剂,在兽医中具有重要的应用.
IVM被世界卫生组织和美国食品和药物管理局批准用于治疗几种人类疾病,包括寄生虫感染和疹.
与兽医选择相比,目前IVM的人类配方是有限的.

研究的目的:

提供关于ivermectin发现,机制和应用的全面概述.
检查与IVM相关的挑战,包括耐药性,副作用和争议.
强调需要通过针对人类和兽医药物量身定制的剂型来优化IVM的输送.

主要方法:

对ivermectin的科学出版物的文献评论.
分析ivermectin在人类和兽医学中的治疗应用和配方.
检查对ivermectin开发的挑战和未来方向.

主要成果:

艾弗梅克显示出对线虫和其他寄生虫的广泛疗效.
在兽医和人类医学之间,IVM配方和施用途径存在显著差异.
目前正在研究IVM对新出现的疾病和疾病的重用潜力.

结论:

通过量身定制的剂量形式,针对性和优化地提供ivermectin对于动物和人类的健康至关重要.
一种健康方法对于将兽医和人类医学的创新相互联系至关重要,以有效控制寄生虫感染.
需要对新型IVM配方进行进一步研究,以提高其治疗效用并克服现有的局限性.

关键词:

它是一种抗菌药物,具有抗菌作用.这是一种抗寄生虫药.这是一种抗病毒药物.剂量形式剂量形式药物重用是为了改变药物的用途.人类人类人类人类人类人类人类传染病是一种传染性疾病.我从来没有使用过mectin.有针对性的药物输送.这是一个兽医兽医兽医.

更多相关视频

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

相关概念视频

Drug Product Performance: In Vitro–In Vivo Correlation

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...